Style
Aggressive GrowthTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | CG Oncology Inc(CGON) | 6,371,669 | $452.7M | 61.87% |
| 2 | Nuvation Bio Inc.(NUVB) | 25,954,439 | $147.4M | 20.15% |
| 3 | Aardvark Therapeutics Inc(AARD) | 3,917,299 | $22.6M | 3.08% |
| 4 | Aclaris Therapeutics, Inc.(ACRS) | 4,041,736 | $21.4M | 2.92% |
| 5 | Upstream Bio Inc.(UPB) | 2,724,868 | $18.9M | 2.58% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 96.33% | 97.85% | +1.52% |
| Unclassified | 3.67% | 2.15% | -1.52% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Arcus Biosciences, Inc(RCUS) |
| 464,779 |
| $14.3M |
| 1.96% |
| 7 | Equillium Inc.(EQ) | 4,447,308 | $14.2M | 1.94% |
| 8 | Revolution Medicines Inc(nsm)(RVMD) | 52,667 | $9.9M | 1.35% |
| 9 | Lyell Immunopharma, Inc. | 692,050 | $9.7M | 1.33% |
| 10 | BeyondSpring Inc.(BYSI) | 3,800,702 | $6.7M | 0.91% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 67.05% | 63.91% | -3.14% |
| Small Cap | 22.84% | 25.65% | +2.81% |
| Micro Cap | 5.06% | 6.95% | +1.89% |
| Unclassified | 3.67% | 2.15% | -1.52% |
| Large Cap | 1.37% | 1.35% | -0.02% |
Quarter-over-quarter position changes